Tag: fda

‘Time to Ground the Plane’: FDA Advisers Recommend JN.1 COVID Vaccines Despite Growing Evidence of Cancer Risks

In a unanimous 16-0 vote, the U.S. Food and Drug Administration’s (FDA) vaccine advisory committee today recommended a monovalent JN.1-lineage vaccine composition for 2024-2025 Formula for COVID-19 vaccines.

The JN.1 variant has been most dominant this year, Reuters reported.

Last year, the agency’s committee recommended COVID-19 vaccines targeting XBB.1.5, a subvariant of Omicron that dominated the U.S. from November 2021 to 2022.

The committee today also discussed which specific strains within the JN.1-lineage group — such as subvariants KP.2 and KP.3 — the vaccines should target. The FDA said it will later issue an official recommendation to manufacturers about what subvariants it wants to target within the JN.1-lineage group.

David Wiseman, Ph.D., a bioscience researcher, told the committee that in recommending continued COVID-19 vaccination, the FDA may be putting the U.S. public’s health at risk. “Based on the totality of evidence, it is reasonable to believe that the product [COVID-19 vaccines] may be unsafe,” he said.

Keep reading

Despite progress in data transparency, the FDA still keeps its data secret

History shows that hiding clinical trial data can be deadly.

Vioxx is a well-known example of how the US drug regulator withheld important information about the harms of the drug for over three years, before it was withdrawn from the market and tens of thousands of people died as a consequence.

Numerous initiatives have been launched over the past two decades to improve access to trial data after it became evident that what was reported in peer-reviewed journals was often cherry-picked and misleading.

Eminent scientists have succeeded in gaining access to trial data from the European and Canadian drug regulators, but a recent analysis published in the Journal of Law, Medicine, & Ethics, found that the US FDA still lags behind others when it comes to data transparency.

Keep reading

FDA detects surge in seizures and heart failure in children who were subjected to COVID-19 jabs

After years of ignoring serious safety signals with the COVID-19 vaccines, the Food and Drug Administration (FDA) finally commissioned a safety study and took a closer look at two serious adverse events that affect young children and adolescents: heart inflammation and seizures.

In a large cohort study involving over 4 million inoculated children, the FDA detected a surge in seizures for children ages 2 to 5. The agency also found a surge in myocarditis and pericarditis in children ages 12 to 17.

“Statistical signals were detected for myocarditis or pericarditis after BNT162b2 vaccination in children aged 12 to 17 years and seizure after vaccination with BNT162b2 and mRNA-1273 in children aged 2 to 4 or 5 years,” the study authors wrote.

Children permanently injured, without scientific rationale or legal recourse

The Pfizer (BNT162b2) and Moderna (mRNA-1273) COVID-19 “vaccines” are responsible for surges in heart inflammation and heart failure in children across the United States. These serious, life-threatening vaccine injuries were predicated on the false belief that children would either die without the jabs or would spread an infection that could kill their elders if they didn’t succumb to the jabs.

Practically every public health entity, institution, and false authority demanded that children be subject to this experiment, and now millions of parents are realizing that they were manipulated into a scam of diabolical proportions.

Of the 73 million American children aged 6 months to 17 years, approximately 26.2 million have completed the primary series of a FDA-licensed COVID-19 vaccine. Another 5.5 million U.S. children had received at least one dose of the primary series.

Keep reading

DISTURBING FDA LOOPHOLE ALLOWS SCIENTISTS TO DO EXPERIMENTS ON HUMANS WITHOUT INFORMED CONSENT

An FDA rule change published on December 21, 2023 solidifies that scientists are allowed to conduct human experiments without informed consent, as long as the research poses “minimal risk” and includes “appropriate safeguards to protect the rights, safety, and welfare of human subjects.” Investigation by ICAN’s legal team revealed that efforts to undermine informed consent protections have long been in the works, going back to at least 1962. ICAN has filed a FOIA request to dig deeper into this violation of one of our most basic human rights.

Informed consent is one of the bedrocks of human rights. It requires that (1) you be fully informed of the risks and benefits of any intervention or procedure and (2) that you consent to participate without coercion of any kind. Unfortunately, it turns out that Congress and our federal health authorities have been working to weaken informed consent protections for over 60 years!

On the heels of FDA’s new draft guidance which further weakens the already paltry clinical trial requirements for vaccine approval, FDA is once again implementing rules that take aim at informed consent protections. On December 21, 2023, FDA issued a final rule that “allows an exception from the requirement to obtain informed consent when a clinical investigation poses no more than minimal risk to the human subject and includes appropriate safeguards to protect the rights, safety, and welfare of human subjects.”

An investigation by ICAN’s attorneys revealed that back in 1962, Congress passed an amendment to the Food, Drug, and Cosmetics Act which directed HHS to create regulations that required researchers to “obtain the consent of such human beings or their representatives, except where they deem it not feasible or, in their professional judgment, contrary to the best interests of such human beings.” (Emphasis added.)

In 1981, both the FDA and HHS issued updated federal regulations regarding “The Protection of Human Subjects.” HHS’s regulations for example “exempt[ed]  broad categories of research which normally present little or no risk of harm to subjects,” such as “study of data, documents, records and specimens.”

Keep reading

FDA Says ‘No Safety Signals’ Linking White Blood Clots To COVID Shots, Despite Embalmer Survey Suggesting Otherwise

White clots in people’s arteries are “really happening” — so why isn’t the phenomena being openly discussed in the public sphere? political commentator Russell Brand asked during a recent episode of his “Stay Free” podcast.

Brand showed viewers a clip of prominent medical commentator John Campbell, Ph.D., interviewing former Air Force Major Thomas Haviland.

Haviland conducted a 2023 survey of 269 embalmers across four major countries and three continents.

According to the survey, more than 70% of embalmers found strange fibrous white blood clots — clots they were not finding pre-pandemic — in significant percentages of corpses in 2023.

Haviland also conducted a similar survey in late 2022 that revealed 66% of embalmers began finding the unusual clots in mid-2021, suggesting a temporal link to the rollout of COVID-19 vaccines, which began earlier that year.

The topic is largely going undiscussed by mainstream news outlets, Brand said, although at least GB News interviewed Campbell to talk about the “white stringy rubbery clots.”

“You’re not really hearing it discussed to the degree that it perhaps ought,” Brand said, “if it is as prevalent as is suggested.”

For instance, Brand cited a Feb. 21 BNN Breaking article that reported Thai neurologist Dr. Thiravat Hemachudha had initially discussed the topic in a Facebook post — but swiftly chose to “cease public discussions on the topic.”

Thiravat is chief of the Thai Red Cross Emerging Infectious Diseases Health Science Centre and a proponent of COVID-19 vaccines.

Keep reading

FDA Not Interested In Reports Of Unusual Blood Clots In Cadavers Around The World Since Covid Pandemic

“Full Measure” host Sharyl Attkisson looks into reports of unknown blood clots being found in cadavers around the world since the COVID-19 pandemic.

“No matter what’s causing this, whether it’s the virus, the vaccine, or whether it’s Cheerios or a bad box of Cracker Jacks, something has to be farmed out what’s causing it, because it’s obviously a change in the blood,” said former Air Force major Tom Haviland.

“The FDA did offer a response to Full Measure,” reported Sharyl Attkisson. “The FDA and the Centers for Disease Control and Prevention (CDC) place a high priority on vaccine safety and are committed to our vaccine safety monitoring program. The FDA has not identified any safety signals for fibrous blood clots with COVID-19 vaccines.”

She added: “They also stated that since the observations were made on cadavers, it ‘falls outside of the FDA’s regulatory purview.'”

Keep reading

SHOCKING: USA has recorded over 1 Million Excess Deaths among the over 65’s since the FDA “approved” the COVID-19 Vaccine

The FDA granted Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine on December 11, 2020, making it the first COVID-19 vaccine to receive such authorization in the United States.

Following that, the Moderna COVID-19 vaccine received EUA on December 18, 2020, and the Janssen (Johnson & Johnson) COVID-19 vaccine received EUA on February 27, 2021.

The elderly were offered the COVID-19 vaccine first and the number of excess deaths recorded was astounding. During the first 20 weeks of 2021 150,085 excess deaths were recorded among people aged over 65’s compared to the 2015 to 2019 five-year average.

Then from week 21 to week 40 of 2021, an astounding 165,387 excess deaths were recorded among people aged 65 and over. This brought the total excess deaths from week 1 to week 40 of 2021 to 315,472 among those most likely to get the COVID-19 vaccine.

The remainder of 2021 saw 133,268 excess deaths recorded. Bringing the total excess deaths for the year among the over 65’s to 448,740.

Keep reading

FDA Admits COVID Vaccine Leads to ‘Significiantly Elevated’ Risk of Seizure in Toddlers

Toddlers and young children are at a “significantly elevated” risk of seizure after taking the COVID-19 vaccine, according to the latest research by the Food and Drug Administration (FDA).

Researchers found that children experienced a 2.5-fold increase in febrile seizures within 24 hours of receiving a Moderna shot compared to the same children between eight to 63 days post-vaccination. There were 88 febrile seizures after the Pfizer vaccination among the study group.

The report states:

In this self-controlled case series that included participants aged 2-5 years from three commercial insurance databases, the incidence rate ratio of febrile seizures was significantly elevated in the 0-1 days following mRNA-1273 administration. Absolute risk was small.

The incidence of febrile seizures was elevated immediately following vaccination with the monovalent mRNA-1273 COVID-19 vaccine in children aged 2-5 years. Based on the current body of evidence, the safety profile of monovalent mRNA vaccines remains favorable for use in young children.

The findings raise further concerns about the various vaccines, which have led to a variety of serious side effects despite being touted by the medical establishment as “safe and effective.”

Keep reading

The Era of Informed Consent is Over

In a significant blow to patient autonomy, informed consent has been quietly revoked just 77 years after it was codified in the Nuremberg Code.

On the 21st of December 2023, as we were frantically preparing for the festive season, the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) issued a final ruling to amend a provision of the 21st Century Cures Act. This allowed 

…an exception from the requirement to obtain informed consent when a clinical investigation poses no more than a minimal risk to the human subject…

This ruling went into effect on January 22nd, 2024, which means it’s already standard practice across America. 

So, what is the 21st Century Cures Act? It is a controversial Law enacted by the 114th United States Congress in January 2016 with strong support from the pharmaceutical industry. The Act was designed to

…accelerate the discovery, development, and delivery of 21st-century cures, and for other purposes [?]…[emphasis added]

Some of the provisions within this Act make for uncomfortable reading. For example, the Act supported: 

High-risk, high-reward research [Sec. 2036].

Novel clinical trial designs [Sec. 3021]

Encouraging vaccine innovation [Sec. 3093].

This Act granted the National Institutes of Health (NIH) legal protection to pursue high-risk, novel vaccine research. A strong case could be made that these provisions capture all the necessary architecture required for much of the evil that transpired over the past four years.

Overturning patient-informed consent was another stated goal of the original Act. Buried under Section 3024 was the provision to develop an

Informed consent waiver or alteration for clinical investigation.

Scholars of medical history understand that the concept of informed consent, something we all take for granted today, is a relatively new phenomenon codified in its modern understanding as one of the critical principles of the Nuremberg Code in 1947. It is inconceivable that just 77 years after Nuremberg, the door has once again opened for state-sanctioned medical experimentation on potentially uninformed and unwilling citizens.  

Keep reading

New Study Finds One Dose of LSD Could Effectively Treat Anxiety in Many Patients

After years of criminalization and marginalization, scientists have begun looking at LSD’s medical benefits more closely, so much so that the Food and Drug Administration just issued a groundbreaking stamp of approval. 

Biopharmaceutical company Mind Medicine announced March 7 that the FDA has awarded “breakthrough therapy” status to its trial of patients using MM120 (lysergide D-tartrate) to treat anxiety. MindMed chief medical officer Daniel Karlin explained what the trial approval means going forward. “A breakthrough designation is a recognition that a drug has demonstrated evidence of clinical efficacy in meeting an unmet medical need with morbidity and mortality associated with it,” he told CNN. The move allows the FDA to “engage more closely in drug development” and speeds up the road to final approval as the agency is involved throughout the process. 

MM120 is the codename for MindMed’s lysergide D-tartrate compound, which resembles and delivers similar effects to lysergic acid diethylamide, known more commonly as LSD. In its ongoing trial, which kicked off in 2022, MindMed has so far found that a single dose of MM120 led to a 48-percent rate of remission from generalized anxiety disorder after 12 weeks following the drug’s administration. Scientists also noted significantly improved clinical signs of generalized anxiety disorder among 65 percent of patients within three months. 

“The clinical improvement for many patients was more than double what we see with today’s standard of care,” Karlin said. “This occurred at all levels of anxiety, from moderate all the way up to severe.”

Keep reading